LEADER 01906nas  2200577-a 450 
001 996216091203316
005 20230227213019.0
011   $a1557-8127
035   $a(OCoLC)52126130
035   $a(CKB)111035998867022
035   $a(CONSER)--2005214262
035   $a(DE-599)ZDB2099740-1
035   $a(EXLCZ)99111035998867022
100   $a20030424a20029999  s--            a
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAssay and drug development technologies
210   $a[Larchmont, NY] $cMary Ann Liebert$d2002-
300   $aRefereed/Peer-reviewed
311   $a1540-658X 
531   $aASSAY DRUG DEV TECHNOL
531   $aAASAY DRUG DEV TECHNOL
531   $aASSAY DRUG DEV TECHN
531   $aASSAY DRUG DEV. TECHNOL
531 0 $aAssay drug dev. technol.
606   $aDrug development$vPeriodicals
606   $aBiological Assay$xmethods
606   $aDrug Evaluation, Preclinical$xinstrumentation
606   $aDrug Evaluation, Preclinical$xmethods
606   $aTechnology, Pharmaceutical$xinstrumentation
606   $aTechnology, Pharmaceutical$xmethods
606   $aBiological Assay$xinstrumentation
606   $aDrug development$2fast$3(OCoLC)fst00898670
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aDrug development
615  2$aBiological Assay$xmethods.
615  2$aDrug Evaluation, Preclinical$xinstrumentation.
615  2$aDrug Evaluation, Preclinical$xmethods.
615  2$aTechnology, Pharmaceutical$xinstrumentation.
615  2$aTechnology, Pharmaceutical$xmethods.
615  2$aBiological Assay$xinstrumentation.
615  7$aDrug development.
676   $a615
906   $aJOURNAL
912   $a996216091203316
996   $aAssay and drug development technologies$92100831
997   $aUNISA